Antiangiogenic resistance via metabolic symbiosis.
Mol Cell Oncol
; 3(5): e1211979, 2016.
Article
in En
| MEDLINE
| ID: mdl-27857974
ABSTRACT
Several types of tumor are currently treated with antiangiogenic drugs. Unfortunately, most of these patients develop therapy resistance and succumb to the disease. Recently, a novel mechanism of resistance to antiangiogenics involving metabolic symbiosis of tumor cells has been described. Strategies to block resistance are emerging as a promising therapeutic approach.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Mol Cell Oncol
Year:
2016
Document type:
Article
Affiliation country:
España